Data-Driven Metabolic Pathway Compositions Enhance Cancer Survival Prediction.
Altered cellular metabolism is an important characteristic and driver of cancer. Surprisingly, however, we find here that aggregating individual gene expression using canonical metabolic pathways fails to enhance the classification of noncancerous vs. cancerous tissues and the prediction of cancer patient survival. This supports the notion that metabolic alterations in cancer rewire cellular metabolism through unconventional pathways. Here we present MCF (Metabolic classifier and feature generator), which incorporates gene expression measurements into a human metabolic network to infer new cancer-mediated pathway compositions that enhance cancer vs. adjacent noncancerous tissue classification across five different cancer types. MCF outperforms standard classifiers based on individual gene expression and on canonical human curated metabolic pathways. It successfully builds robust classifiers integrating different datasets of the same cancer type. Reassuringly, the MCF pathways identified lead to metabolites known to be associated with the pertaining specific cancer types. Aggregating gene expression through MCF pathways leads to markedly better predictions of breast cancer patients' survival in an independent cohort than using the canonical human metabolic pathways (C-index = 0.69 vs. 0.52, respectively). Notably, the survival predictive power of individual MCF pathways strongly correlates with their power in predicting cancer vs. noncancerous samples. The more predictive composite pathways identified via MCF are hence more likely to capture key metabolic alterations occurring in cancer than the canonical pathways characterizing healthy human metabolism.
Center for Bioinformatics and Computational Biology and the Department of Computer Science, University of Maryland, College Park, Maryland, United States of America.
Noam
N
Auslander
Department of Electrical Engineering and Computer Science and the Center for Computational Biology, University of California, Berkeley, Berkeley, California, United States of America.
Allon
A
Wagner
Center for Bioinformatics and Computational Biology and the Department of Computer Science, University of Maryland, College Park, Maryland, United States of America.
Matthew
M
Oberhardt
Center for Bioinformatics and Computational Biology and the Department of Computer Science, University of Maryland, College Park, Maryland, United States of America.|The Blavatnik School of Computer Science and the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Eytan
E
Ruppin
Nat Genet. 2007 Nov;39(11):1338-49
17922014
Prostate Cancer Prostatic Dis. 2012 Jun;15(2):150-6
22343836
Biomed Sci Instrum. 2012;48:112-8
22846272
J Cell Biochem. 2013 Jul;114(7):1665-73
23386399
Cell Mol Life Sci. 2004 Jun;61(11):1372-83
15170515
Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6994-9
20335537
Cancer Res. 2006 Jun 15;66(12):5977-80
16778164
Stat Med. 1996 Feb 28;15(4):361-87
8668867
Cell Metab. 2008 Jan;7(1):11-20
18177721
Nature. 2011 Aug 18;476(7360):346-50
21760589
BMC Bioinformatics. 2012 May 01;13:69
22548963
PLoS Comput Biol. 2014 Sep 18;10(9):e1003851
25233347
PLoS Comput Biol. 2012;8(2):e1002375
22383865
Mol Cancer Ther. 2007 Jan;6(1):128-37
17237273
PLoS Comput Biol. 2009 Aug;5(8):e1000489
19714220
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2685-9
15710883
Front Genet. 2013 Dec 23;4:289
24391662
Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1777-82
17267599
Nat Rev Cancer. 2013 Apr;13(4):227-32
23446547
Cell. 2011 Mar 4;144(5):646-74
21376230
Breast Cancer Res Treat. 2010 Jan;119(2):335-46
19266279
Mol Syst Biol. 2007;3:140
17940530
Nat Biotechnol. 2013 Jun;31(6):522-9
23604282
Mol Syst Biol. 2014 Aug 01;10:744
25086087
Cell Metab. 2016 Jan 12;23 (1):27-47
26771115
Biostatistics. 2007 Apr;8(2):212-27
16698769
J Pharmacol Sci. 2007 Jan;103(1):24-32
17220595
PLoS Comput Biol. 2008 Nov;4(11):e1000217
18989396
Mol Syst Biol. 2014 Jul 01;10:737
24987116
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
11752295
Cancer Cell. 2012 Mar 20;21(3):297-308
22439925
Nat Biotechnol. 2009 Feb;27(2):199-204
19182785
PLoS Comput Biol. 2011 Oct;7(10):e1002240
22028643
Nature. 2012 Apr 18;486(7403):346-52
22522925
Genome Med. 2016 Mar 31;8(1):34
27036109
Bioinformatics. 2010 Sep 15;26(18):i625-31
20823331
Cell. 2008 Sep 5;134(5):703-7
18775299
Nature. 2012 Mar 28;483(7391):603-7
22460905
BMC Syst Biol. 2010 May 06;4:58
20459610
Science. 2009 May 22;324(5930):1029-33
19460998
Cancer Res. 1989 Jul 15;49(14):3829-33
2544259
PLoS One. 2012;7(4):e34796
22558100
Cancer Genomics Proteomics. 2012 Mar-Apr;9(2):67-75
22399497
Mol Syst Biol. 2011 Jun 21;7:501
21694718
Nat Rev Cancer. 2007 Oct;7(10):763-77
17882277
J Natl Cancer Inst. 2004 Aug 4;96(15):1152-60
15292387
Int J Nanomedicine. 2012;7:2293-306
22619562
Bioinformatics. 2015 Jun 15;31(12):i311-9
26072498